课题基金 / 基金详情

项目摘要

项目成果

Carlos L Arteaga的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overarching goal of the Simmons Comprehensive Cancer Center (SCCC) Administration is to provide an efficient and effective administrative environment that nurtures and supports the Center's mission and vision. Administration's specific goals are to deliver value-added support to Cancer Center members by providing stellar administrative support and leadership in facilitating collaborative, transdisciplinary, and multi-investigator research; decision-making data from its information technology platforms; strategic planning implementation, and monitoring; and support for the other CCSG components essential to SCCC, such as shared resources, clinical protocol and data management, developmental funds, and planning and evaluation. Administration's services include: • Management of the CCSG application, progress reports, and supplements • Financial coordination and oversight, including budgeting and management of philanthropic resources • Management of the membership processes, research and grants activities, and SCCC space • Coordination of pilot funding mechanisms • Oversight and management of operational aspects of the shared resources • Representation of SCCC among UTSW institutional entities and collaboration with their representatives • Support for faculty recruitment, retention, promotion, and tenure • Coordination and documentation of Center meetings • Human resource management for CCSG personnel
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Neoadjuvant Neratinib in Stage I-III HER2-mutated Lobular Breast Cancer
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    9759820
  • 项目类别:
  • 资助金额:
    $35.74万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    10214565
  • 项目类别:
  • 资助金额:
    $36.83万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
Role of HER2 mutations in breast cancer progression and response to targeted therapies
  • 批准号:
    10458531
  • 项目类别:
  • 资助金额:
    $36.09万
  • 财政年份:
    2018
  • 负责人:
    Carlos L Arteaga
  • 依托单位:
海外基金